Lymphocyte-infiltrated FIGO Stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival

European Journal of Gynaecological Oncology

Volumn 20, Issue 2, 1999, Pages 136-140

  Chao, Hsiang Tai ^a,c   Wang, P H ^a   Tseng, J Y ^b   Lai, C R ^a   Chiang, S C ^a   Yuan, C C ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Disease free survival; Staging IIB squamous cell carcinoma of the cervix

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE SYSTEM; LYMPH NODE DISSECTION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOCYTES; MEDICAL RECORDS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0032992796     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Chang P. Y.: "Cancer Registry Annual Report". R.O.C. Taipei: Department of Health R.O.C., 1996.
2. Friedberg V., Beck T.: "Results of surgical treatment of stage IIb cervical cancer". Geburtshilfe und Frauenheikunde, 1989, 49, 782.
3. Friedberg V.: "Operative therapy for stage IIB cervical cancer". Baillieres Clin. Obstet. Gynecol. 1988, 1, 973.
4. Kurman R. J., Norris H. J., Wilkinson E. J.: "Atlas of tumor pathology. Tumors of the cervix, vagina, and vulva". Washington DC. Armed Forces Institute of Pathology, 1992.
5. Wang P. H., Liu R. C., Lai C. R., Chao H. T., Yuan C. C., Yu K. J.: "Small cell carcinoma of the cervix: analysis of clinical and pathological findings". Eur. J. Gynecol. Oncol., 1998, 19, 189.
6. SAS/STAT user's guide, release 6.03 edition. Cary (NC): SAS Institute, 1988.
7. Kaplan E. L., Meier P.: "Non-parametric estimation from incomplete observation". J. Am. Stat. Assoc., 1986, 4, 57.
8. Mantel N.: "Evaluation of survival data and two rank-order statistics arising in its consideration". Cancer Chemother. Rep., 1966, 50, 163.
9. Cox D. R.: "Regression models and life tables". J. Roy. Stat. Soc. B., 1972, 34, 187.
10. Santoni R., Baldini B., Lastrucci L., Moncini D., Mungai R., Taddei G. et al.: "Clinical stage IIB carcinoma of the uterine cervix: results in 122 patients". Eur. J. Gynecol. Oncol., 1996, 17, 212.
11. Chiara S., Bruzzone M., Merlini L., Bruzzi P., Rosso R., Franzone P. et al.: "Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma". Am. J. Clin. Oncol., 1994, 17, 294.
12. Bonetti B., Frata P., La Face B., Baroncelli G.: "Exclusive radiotherapy in the treatment of carcinoma of the portio cervices, stage IIB FIGO". Radiologia Medica, 1992, 83, 641.
13. DiSaia P. J., Bundy B. N., Curry S. L., Schlaerth J., Thigpen J. T.: "Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous coryne-bacterium parvum: a Gynecologic Oncology Group study". Gynecol. Oncol., 1987, 26, 386.
14. Lei Z. Z., He F. Z.: "External cobalt 60 irradiation alone for stage IIB carcinoma of the uterine cervix". Int. J. Rad. Oncol. Biol. Physics, 1989, 16, 339.
15. Gynning I., Johnsson J. E., Alm P., Trope C.: "Age and prognosis in stage IB squamous cell carcinoma of the uterine cervix". Gynecol. Oncol., 1983, 75, 18.
16. Kjorstad K. E.: "Carcinoma of the cervix in the young patients". Obstet. Gynecol., 1977, 50, 28.
17. Stanhope C. R., Smith T. P., Wharton J. T., Rutledge F. N., Fletcher G. H., Gallager H. S.: "Carcinoma of cervix: the effect of age on survival". Gynecol. Oncol., 1980, 10, 188.
18. Alvarez R. D., Soong S. J., Kinney W. K. et al.: "Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix". Gynecol. Oncol., 1989, 35, 130.
19. Lai C. H., Chang H. C., Chang T. C., Hsueh S., Tang S. G.: "Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases". Gynecol. Oncol., 1993, 51, 390.
20. Smiley L. M., Burke T. W., Silva E. G., Morris M., Gershenson D. M., Wharton J. T.: "Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence". Gynecol. Oncol., 1991, 77, 271.
21. Lee Y. N., Wang K. L., Lin M. H. et al.: "Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases". Gynecol. Oncol., 1989, 32, 135.
22. Sigurdsson K., Harfnkelsson J., Geirsson G., Gudumundsson J., Salvarsdottir A.: "Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factor based on Icelandic population data, 1964-1988". Gynecol. Oncol., 1991, 43, 64.
23. Bjorge T., Thoresen S. O., Skare G. B.: "Incidence, survival and mortality in cervical cancer in Norway, 1956-1990". Eur. J. Cancer, 1993, 29, 2291.
24. Girardi F., Fuchs P., Haas J.: "Prognostic importance of human papillomavirus type 16 DNA in cervical cancer". Cancer, 1992, 69, 2502.
25. Yuan C. C., Wang P. H., Lai C. R., Tsu E. J., Yen M. S. Ng H. T.: "Recurrence and survival analyses of 1115 cervical cancer patients treated with radical hysterectomy". Gynecol. Obstet. Invest., 1998 (In press).
26. Yuan C. C., Wang P. H., Lai C. R., Yen M. S., Chen C. Y. Juang C. M.: "Prognosis-predicting system based on factors related to survival of cervical carcinoma". Int. J. Gynecol. Obstet., 1998 (In press).
27. Perez C. A., Kao M. S.: "Radiation therapy alone or in combination with surgery in the treatment of barrel-shaped carcinoma of the uterine cervix (stage IB, IIA, and IIB)". Int. J. Radial. Oncol. Bio. Phy., 1985, 11, 1903.
28. Srisupundit S., Tangtrakul S., Linasmita V., Bullangpoti S., Kraiphibul P., Pojchanugool L.: "Combined radiotherapy and hysterectomy in the treatment of high risk stage II invasive carcinoma of the uterine cervix". Jap. J. Cancer Chemotherapy, 1995, 3, 255.
29. Ptackova B., Kucera F., Tacev T., Kabela M., Kopecny J., Spurny V., Zatocil P.: "Stage IIB, IIIB, and IVA carcinoma of the uterine cervix-results of treatment by radiotherapy in 649 patients". Neoplasma, 1987, 34, 337.
30. Nicolson G. L.: "Cell surface molecules and tumor metastasis: regulation of metastatic phenotypic diversity". Exp. Cell. Res., 1984, 150, 3.
31. Goldfarb R. H., Kitson R. P., Brunson K. W.: "Biology of cancer metastases: hematogeneous dissemination". In: Lotze M. T., Rubin J. T. eds. "Regional therapy of advanced cancer". Lippincott-Raven Publishers. Philadelphia, 1997, 1.
32. Underwood J. C.: "Lymphorecticular infiltration in human tumors, prognostic and biological implications: a review". Br. J. Cancer, 1974, 30, 538.
33. Jass J. R., Atkin W. S., Cuzick J. et al.: "The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases". Histopathology, 1986, 10, 437.
34. Berg J. W.: "Inflammation and prognosis in breast cancer: a search for host resistance". Cancer, 1959, 12, 714.
35. Nicolson G. L., Poste G.: "The cancer cell: dynamic aspects and modifications in cell-surface organization". N. Engl. J. Med., 1976, 295, 253.
36. Jass J. R.: "Lymphocytic infiltration and survival in rectal cancer". J. Clin. Pathol., 1986, 39, 585.
37. Watt A. G., House A. K.: "Colonic carcinoma: a quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis". Cancer, 1978, 41, 279.
38. Kubota Y., Sunouchi K., Ono M., Sawada T., Muto T.: "Local immunity and metastasis of colorectal carcinoma". Dis. Colon Rectum., 1992, 35, 645.
39. Pupa S. M., Bufalino R., Invernizzi A. M. et al.: "Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas". J. Clin. Oncol., 1996, 14, 85.
40. Tazi A., Bouchonnet F., Grandsaigne M. et al.: "Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers". J. Clin. Invent., 1993, 91, 566.
41. Zeid N. A., Muller H. K.: "HK S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival". Pathology, 1993, 25, 338.
42. Lotze M. T.: "Biology of cancer metastases: Lymphatic dissemination". In: Lotze M. T., Rubin J. T., eds. "Regional therapy od advanced cancer". Lippincott-Raven publishers. Philadelphia, 1997, 1.
43. Nakano T., Oka K., Takahashi T., Morita S., Arai T.: "Roles of Langerhans' cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer". Cancer, 1992, 70, 2839.
44. Nakano T., Oka K., Arai T., Morita S., Tsunemoto H.: "Prognostic significance of Langerhans' cells infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix". Arch. Pathol. Lab. Med., 1989, 113, 507.
45. Serenella M., Bufalino R., Invernizzi A. M. et al.: "Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas". J. Clin. Oncol., 1996, 14, 85.
46. Tazi A., Bouchonnet F., Grandsaigne M., Boumsell L., Hance A. J., Soler P.: "Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers". J. Clin. Invest., 1993, 91, 566.
47. Tosi P., Sforza V., Santopietro R. et al.: "Bronchiolo-alveolar carcinoma: an analysis of survival predictors". Eur. J. Cancer, 1992, 28A, 1365.